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Summary We describe a 59-year-old woman with sick sinus syndrome (SSS) and
arrhythmogenic right ventricular cardiomyopathy (ARVC). Diagnosis of SSS was made
because she had frequent episodes of sinus arrest with prolonged ventricular asys-
tole. Cardiac images showed a dilated right atrium (RA) and a right ventricle
(RV). Electroanatomical mapping of the RA showed extensive scarring with no
recordable electrical potentials. Although she had frequent premature ventricu-Bradycardia;
Ventricular arrhythmia;
Atrium
lar contractions, neither spontaneous ventricular tachycardia (VT) nor induced VT
was observed. Microscopic examination of the RV indicated ﬁbrofatty myocardium.
Atrial arrhythmias associated with SSS may be the cause of symptoms in some cases
of ARVC.
© 2008 Japanese College of Cardiology. Published by Elsevier Ireland Ltd. All rights
preserved.
ntroductionrrhythmogenic right ventricular dysplasia/cardio-
yopathy (ARVC) is a myocardial disease that
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oi:10.1016/j.jjcc.2008.03.003rimarily affects the right ventricle (RV) with
eplacement of the myocardium by fatty and
brous tissues [1—8]. The predominant present-
ng symptoms are due to ventricular arrhythmias,
ncluding palpitation, ventricular tachycardia (VT),
r uncommonly, sudden cardiac death. This report
escribes a case of atrial abnormalities in a patient
ith ARVC without VT.
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 (A) Twelve-lead surface electrocardiogram. The tracing shows narrow QRS rhythm. There are no clear P
waves. The T waves are inverted in lead V1—4. (B) Signal-averaged electrocardiogram shows negative late potentials.
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Case report
A 59-year-old woman was admitted to hospital
because of bradycardia, faintness, and dyspnea on
effort. Her family history was negative for cardiac
arrhythmia and sudden cardiac death. Labora-
tory examination showed atrial natriuretic peptide
(ANP) 14.4 pg/ml (normal range <43.0 pg/ml) and
brain natriuretic peptide (BNP) 43.0 pg/ml (normal
range <18.4 pg/ml). A chest X-ray showed increased
cardiothoracic ratio of 59% without pulmonary inﬁl-
trate. A 12-lead electrocardiogram (ECG) showed
no clear P wave preceded narrow QRS rhythm,
and T wave inversion in leads V1—4 (Fig. 1A).
Signal-averaged ECG (SAECG) showed negative late
potentials (Fig. 1B). Diagnosis of sick sinus syn-
drome (SSS) was made because of multiple 24-h
Holter ECGs showed frequent episodes of sinus
arrest with prolonged ventricular asystole (>5.0 s).
Although she also had frequent episodes of prema-
ture ventricular contractions (PVCs), VT was not
observed. Transthoracic echocardiography showed
dilated right atrium (RA) and RV. The echocardio-
graphic left ventricular (LV) end-diastolic diameter
was 42mm, and the LV ejection fraction (EF)
was 71%. Technetium-99m cardiac blood pool scan
revealed an enlargement of RV cavity with an EF
of 32%. Cardiac magnetic resonance image also
showed the dilated RA and the RV (Fig. 2).
During the electrophysiological study, although
the P wavemorphology was unclear, the patient was
in atrial rhythm with atrio-His intervals of 280ms
and His-ventricular intervals of 50ms, respectively.
The RA was electrically silent with no capture dur-
ing electrical stimulation at all sites, except for
u
o
r
ie last 40ms of the QRS complex 17.7V.
mall areas in the lower RA. Sinus node recov-
ry time could not be evaluated because of atrial
verdrive pacing was difﬁcult, however, frequent
pontaneous atrial arrest with a maximum inter-
al of 3.5 s was observed. Endocardial mapping was
erformed using an electroanatomical mapping sys-
em (CARTO, Biosense Webster, Diamond Bar, CA,
SA) during the coronary sinus high output pac-
ng since the patient’s atrial rhythm was unstable
Fig. 3A). A voltage map of the RA showed extensive
carring with no recordable electrical potentials
nd small areas of low-voltage potentials (<0.1mV).
he voltage map also showed areas of low-voltage
nd delayed potentials in the RV. Programmed ven-
ricular stimulation using two sites (RV apex and RV
utﬂow tract), three extrastimuli, and burst pacing
ailed to induce VT.
A cardiac biopsy was performed. Microscopic
xamination of the RV septum indicated ﬁbrofatty
eplacement of the myocardium (Fig. 3B). After
onﬁrmation of the diagnosis of SSS and ARVC,
permanent pacemaker implantation was per-
ormed. A single chamber ventricular pacemaker
ENPULSE E2SR01, Medtronic Inc., Minneapolis, MN,
SA) was implanted due to poor sensing and high
acing threshold in the RA. The pacing lead (5076,
edtronic) was positioned in the RV septum. The
ensed R wave was 4.0mV, and the pacing thresh-
ld was 0.7 V at a pulse width of 0.5ms. The
acing mode was programmed to VVIR pacing at
0—110 beats/min. The postoperative course was
neventful and the patient was discharged with-
ut symptoms. After 4 months of VVIR pacing, she
emained clinically well, and her laboratory exam-
nation showed ANP 5.0 pg/ml and BNP 23.8 pg/ml.
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vigure 2 Cardiac magnetic resonance imaging. Cardiac
ion and small aneurysmal formation (arrows). The right
entricle; RA, right atrium; RV, right ventricle.
iscussion
his patient had enlarged RV and reduction of the
VEF with no LV impairment, inverted T waves in
ight precordial leads, frequent PVCs and ﬁbrofatty
nﬁltration of the myocardium, which were enough
o make a diagnosis of ARVC according to the TASK
orce Criteria [1]. ARVC is a disease in which normal
yocardium is replaced by ﬁbrofatty tissue, causing
hinning and scaring, predominantly in the RV. How-
ver, the most remarkable feature of this case was
he morphological and electrophysiological abnor-
alities in the RA.
There are some reports that the atrial diame-er are enlarged in patients with ARVC [4,5]. In
ddition, ﬁbrofatty replacement of the RA with
ssociated SSS in patients ARVC has been demon-
trated [9,10]. However, the mechanisms for atrial
w
a
R
Aetic resonance imaging showing right ventricular dilata-
um is also dilated. The left ventricle is normal. LV, left
bnormalities in patients with ARVC are not well
nderstood. On the other hand, electroanatomi-
al mapping system can be used to estimate both
he electrophysiology and the anatomical mor-
hology. In this patient, electroanatomical map of
he RA presented a better understanding of the
nique electrical anatomy of the arrhythmia sub-
trate. The map highlights the predisposition of
he RA to develop the SSS and the enlargement.
he bipolar voltage map of the RA in this patient
howed extensive scarring with no recordable
lectrical potentials. Previous electroanatomical
tudies have shown that the mean RA bipolar
oltage amplitude during atrial pacing in patients
ith sinus node disease was 1.1± 0.2mV [11]. The
uthors speculate that this case shows exclusive
A abnormality, which is occasionally involved in
RVC.
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Figure 3 (A) Electroanatomical bipolar voltage map of the right atrium (RA) and right ventricle (RV) during coronary
sinus pacing. The right anterior oblique view is shown. Red regions on the map represent scars (voltage <0.1mV) and
gray regions represent the no potential zone. As demonstrated by the color-coded key, purple represents voltage
>0.5mV. The RA map showing extensive scarring with no recordable electrical potentials and small areas of low
voltage potentials. Scar in the RV is located in basal RV and RV outﬂow tract. Low voltage and delayed potentials
are recorded in basal RV (turquoise blue dots). (B) Endomyocardial biopsy. Endomyocardial biopsy specimen obtained
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In the present case, the plasma BNP concentra-
tion was higher than normal range. Previous report
have indicated that RVEF is inversely correlated
with BNP and ANP [12]. In addition, such high levels
of BNP is reported in ARVC [2]. On the other hand,
this patient plasma ANP concentration remained
relatively low despite the enlarged RA. Although
ANP is produced by atrium secondary to atrial
stretch, previous studies suggest that loss of atrial
myocytes or atrial ﬁbrosis leads to reduced ANP pro-
duction capacity [13,14]. Indeed, it was shown that
atrial standstill or atrial ﬁbrillation with long his-
tory is characterized by low levels of ANP [14,15].
Normal ANP level in our patient may be associ-
ated with atrial structural abnormalities due to
ARVC.
In this case, histopathological examination of
the RA was not performed. Therefore, the precise
pathologic mechanism of the SSS in this case was
not determined. However, atrial arrhythmias asso-
ciated with SSS may be the cause of symptoms in
some cases of ARVC. Vigilant attention should be
paid to the evaluation of SSS.
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Ains, magniﬁcation ×40). Fibrofatty replacement of the
Detailed electroanatomical mapping is helpful
n deﬁning the pathologic substrate and in recon-
tructing VT circuits in ARVC [3,6,8]. Although, the
AECG in this patient showed negative late poten-
ials, the electroanatomical mapping demonstrated
elayed potentials in the RV. On the other hand, nei-
her spontaneous VT nor induced VT was observed
n this case. The absence of VT might suggest that
he arrhythmia substrate in the RV was insufﬁcient
or the initiation and perpetuation of VT. Further-
ore, the SAECG may not be sensitive enough to
emonstrate areas of localized conduction delay in
he RV.
The treatment of ARVC is individualized. An
mplantable cardioverter deﬁbrillator (ICD) is
ssential for the survivors of sudden death or
atients with refractory VT. Efﬁcacy of prophylac-
ic ICD therapy has been shown to prevent sudden
ardiac death in ARVC [7]. Since our patient had
o spontaneous VT and the VT study was negative,
e decided to use the permanent pacemaker as
mplantable arrhythmic device. However, because
RVC is a progressively degenerative disease, she
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emains under close observation for possibility of
T in the future.
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